SBIR/STTR Research Award
FEASIBILITY STUDY OF A PHARMACEUTICAL CASE - MANAGEMENT PROGRAM TO CONTROL COSTS AND INCREASE QUALITY OUTCOMES OF PHARMACEUTICAL RELATED CARE
Award amount
$99,933Program and phase
SBIR · Phase IIAward year
1992Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Mikalix And Company
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP CASEMED, A PHARMACEUTICAL CASE MANAGEMENT SOFTWARE PROGRAM, TO IMPROVE HEALTH OUTCOMES AND CONTROL COSTS THAT RESULT FROM INAPPROPRIATE PHARMACEUTICAL THERAPIES IN THE ELDERLY. THISPHASE I FEASIBILITY STUDY DEMONSTRATED BOTH THE CLINICAL NEED AND COST EFFECTIVENESS OF A TOOL TO CONDUCT FOCUSED MANAGEMENT OF GERIATRIC THERAPEUTIC DRUG REGIMENS. CASEMED FOCUSES ON ELDERLY PATIENTS WHO ACCOUNT FOR THE PREPONDERANCE OF PHARMACEUTICAL USE. THE CONCLUSION IS THATCASEMED IS BOTH TECHNOLOGICALLY AND COMMERCIALLY FEASIBLE. THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP CASEMED, A PHARMACEUTICAL CASE MANAGEMENT SOFTWARE PROGRAM, TO IMPROVE HEALTH OUTCOMES AND CONTROL COSTS THAT RESULT FROM INAPPROPRIATE PHARMACEUTICAL THERAPIES IN THE ELDERLY. THISPHASE I FEASIBILITY STUDY DEMONSTRATED BOTH THE CLINICAL NEED AND COST EFFECTIVENESS OF A TOOL TO CONDUCT FOCUSED MANAGEMENT OF GERIATRIC THERAPEUTIC DRUG REGIMENS. CASEMED FOCUSES ON ELDERLY PATIENTS WHO ACCOUNT FOR THE PREPONDERANCE OF PHARMACEUTICAL USE. THE CONCLUSION IS THATCASEMED IS BOTH TECHNOLOGICALLY AND COMMERCIALLY FEASIBLE.
Technology keywords
Not reported